Translatability of life‐extending pharmacological treatments between different species
Aging Cell · 2024
DOI: 10.1111/acel.14208 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging Cell, 2024. Verfasst von Daiana Burdusel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, University of Medicine and Pharmacy of Craiova, Craiova, Romania. Hauptthemen laut MEDLINE: Longevity. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Executive Agency for Higher Education, Research, Development and Innovation Funding, German Research Foundation.
Abstract (Originalsprache)
Anti‐aging research has made significant strides in identifying treatments capable of extending lifespan across a range of organisms, from simple invertebrates to mammals. This review showcases the current state of anti‐aging interventions, highlighting the lifespan extensions observed in animal models through various treatments and the challenges encountered in translating these findings to humans. Despite promising results in lower organisms, the translation of anti‐aging treatments to human applications presents a considerable challenge. This discrepancy can be attributed to the increasing complexity of biological systems, species‐specific metabolic and genetic differences, and the redundancy of metabolic pathways linked to longevity. Our review focuses on analyzing these challenges, offering insights into the efficacy of anti‐aging mechanisms across species and identifying key barriers to their translation into human treatments. By synthesizing current knowledge and identifying gaps in translatability, this review aims to underscore the importance of advancing these therapies for human benefit. Bridging this gap is essential to assess the potential of such treatments in extending the human healthspan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
- Chair of Vascular Neurology and Dementia, Department of Neurology, University Hospital Essen, Essen, Germany.
- Cantacuzino National Medical Military Institute for Research and Development, Bucharest, Romania.
- Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
- Department of Neurology, University of Giessen Medical School, Giessen, Germany.
- Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, New York, USA.
ORCID-Profile: Aurel Popa-Wagner
Förderung
- European Union
- Executive Agency for Higher Education, Research, Development and Innovation Funding
- German Research Foundation
- German Federal Ministry of Education and Science
- European Commission
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Burdusel, D., Coman, C., Ancuta, D. L., Hermann, D. M., Doeppner, T. R., Gresita, A., & Popa-Wagner, A. (2024). Translatability of life‐extending pharmacological treatments between different species. Aging Cell. https://doi.org/10.1111/acel.14208
Vancouver
Burdusel D, Coman C, Ancuta DL, Hermann DM, Doeppner TR, Gresita A, et al. Translatability of life‐extending pharmacological treatments between different species. Aging Cell. 2024. doi:10.1111/acel.14208
BibTeX
@article{Burdusel2024,
author = {Burdusel, Daiana and Coman, Cristin and Ancuta, Diana-Larisa and Hermann, Dirk M and Doeppner, Thorsten R and Gresita, Andrei and Popa-Wagner, Aurel},
title = {Translatability of life‐extending pharmacological treatments between different species},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14208}
}
EUVIMED